APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Analysis Services

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pharmaceutical Analysis Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

3 May 2026198 pages

Choose your research edition.

Industry ResearchPharmaceutical Analysis Services Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Analysis Services Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Analysis Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Analysis Services Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Analysis Services Market Analysis and Forecast 2026-2032187 pages · $4,950 USD

Market perspective

The global Pharmaceutical Analysis Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Pharmaceutical Analysis Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical Analysis Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical Analysis Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pharmaceutical Analysis Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pharmaceutical Analysis Services include Eurofins, WuXi AppTec, Pace Analytical Services, Catalent, LabCorp (Covance), PPD, Element (Exova), ALS Pharmaceutical and Intertek Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Pharmaceutical Analysis Services market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical Analysis Services and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical Analysis Services revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Pharmaceutical Analysis Services market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharmaceutical Analysis Services Segment by Company

Eurofins

WuXi AppTec

Pace Analytical Services

Catalent

LabCorp (Covance)

PPD

Element (Exova)

ALS Pharmaceutical

Intertek Group

SGS

Boston Analytical

DYNALABS

ADPEN Laboratories

ARL Bio Pharma

West Pharmaceutical

Microbac

Element (Analytical Lab Group)

Piramal Pharma Solutions

CTI

Weipu

PONY Medicine

Pharmaceutical Analysis Services Segment by Type

Raw Material Analysis

Microbiological Analysis

Drug Packaging Material Analysis

Biological Analysis and Testing

Other

Pharmaceutical Analysis Services Segment by Application

CRO

CMO and CDMO

Finished Drugs and Environment

Pharmaceutical Analysis Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Analysis Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Analysis Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Analysis Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Pharmaceutical Analysis Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Analysis Services industry.

Chapter 3: Detailed analysis of Pharmaceutical Analysis Services companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical Analysis Servicesrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharmaceutical Analysis Services Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Raw Material Analysis Table 3. Key Players of Microbiological Analysis Table 4. Key Players of Drug Packaging Material Analysis Table 3. Key Players of Biological Analysis and Testing Table 4. Key Players of Other Table 5. Global Pharmaceutical Analysis Services Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of CRO Table 7. Key Players of CMO and CDMO Table 8. Key Players of Finished Drugs and Environment Table 9. Global Pharmaceutical Analysis Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Pharmaceutical Analysis Services Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Pharmaceutical Analysis Services Market Share by Region (2021-2026) Table 12. Global Pharmaceutical Analysis Services Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Pharmaceutical Analysis Services Market Share by Region (2027-2032) Table 14. Pharmaceutical Analysis Services Industry Trends Table 15. Pharmaceutical Analysis Services Industry Drivers Table 16. Pharmaceutical Analysis Services Industry Opportunities and Challenges Table 17. Pharmaceutical Analysis Services Industry Restraints Table 18. Global Pharmaceutical Analysis Services Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Pharmaceutical Analysis Services Revenue Market Share by Company (2021-2026) Table 20. Global Pharmaceutical Analysis Services Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Pharmaceutical Analysis Services Key Company Head Office and Area Served Table 22. Global Pharmaceutical Analysis Services Company, Product Type & Application Table 23. Global Pharmaceutical Analysis Services Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Pharmaceutical Analysis Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Pharmaceutical Analysis Services Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pharmaceutical Analysis Services Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Pharmaceutical Analysis Services Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Pharmaceutical Analysis Services Revenue Market Share by Type (2021-2026) Table 30. Global Pharmaceutical Analysis Services Revenue Market Share by Type (2027-2032) Table 31. Global Pharmaceutical Analysis Services Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Pharmaceutical Analysis Services Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Pharmaceutical Analysis Services Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Pharmaceutical Analysis Services Revenue Market Share by Application (2021-2026) Table 35. Global Pharmaceutical Analysis Services Revenue Market Share by Application (2027-2032) Table 36. Eurofins Company Information Table 37. Eurofins Business Overview Table 38. Eurofins Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Eurofins Pharmaceutical Analysis Services Product Portfolio Table 40. Eurofins Recent Development Table 41. WuXi AppTec Company Information Table 42. WuXi AppTec Business Overview Table 43. WuXi AppTec Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. WuXi AppTec Pharmaceutical Analysis Services Product Portfolio Table 45. WuXi AppTec Recent Development Table 46. Pace Analytical Services Company Information Table 47. Pace Analytical Services Business Overview Table 48. Pace Analytical Services Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Pace Analytical Services Pharmaceutical Analysis Services Product Portfolio Table 50. Pace Analytical Services Recent Development Table 51. Catalent Company Information Table 52. Catalent Business Overview Table 53. Catalent Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Catalent Pharmaceutical Analysis Services Product Portfolio Table 55. Catalent Recent Development Table 56. LabCorp (Covance) Company Information Table 57. LabCorp (Covance) Business Overview Table 58. LabCorp (Covance) Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. LabCorp (Covance) Pharmaceutical Analysis Services Product Portfolio Table 60. LabCorp (Covance) Recent Development Table 61. PPD Company Information Table 62. PPD Business Overview Table 63. PPD Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. PPD Pharmaceutical Analysis Services Product Portfolio Table 65. PPD Recent Development Table 66. Element (Exova) Company Information Table 67. Element (Exova) Business Overview Table 68. Element (Exova) Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Element (Exova) Pharmaceutical Analysis Services Product Portfolio Table 70. Element (Exova) Recent Development Table 71. ALS Pharmaceutical Company Information Table 72. ALS Pharmaceutical Business Overview Table 73. ALS Pharmaceutical Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. ALS Pharmaceutical Pharmaceutical Analysis Services Product Portfolio Table 75. ALS Pharmaceutical Recent Development Table 76. Intertek Group Company Information Table 77. Intertek Group Business Overview Table 78. Intertek Group Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Intertek Group Pharmaceutical Analysis Services Product Portfolio Table 80. Intertek Group Recent Development Table 81. SGS Company Information Table 82. SGS Business Overview Table 83. SGS Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. SGS Pharmaceutical Analysis Services Product Portfolio Table 85. SGS Recent Development Table 86. Boston Analytical Company Information Table 87. Boston Analytical Business Overview Table 88. Boston Analytical Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Boston Analytical Pharmaceutical Analysis Services Product Portfolio Table 90. Boston Analytical Recent Development Table 91. DYNALABS Company Information Table 92. DYNALABS Business Overview Table 93. DYNALABS Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. DYNALABS Pharmaceutical Analysis Services Product Portfolio Table 95. DYNALABS Recent Development Table 96. ADPEN Laboratories Company Information Table 97. ADPEN Laboratories Business Overview Table 98. ADPEN Laboratories Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. ADPEN Laboratories Pharmaceutical Analysis Services Product Portfolio Table 100. ADPEN Laboratories Recent Development Table 101. ARL Bio Pharma Company Information Table 102. ARL Bio Pharma Business Overview Table 103. ARL Bio Pharma Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. ARL Bio Pharma Pharmaceutical Analysis Services Product Portfolio Table 105. ARL Bio Pharma Recent Development Table 106. West Pharmaceutical Company Information Table 107. West Pharmaceutical Business Overview Table 108. West Pharmaceutical Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 109. West Pharmaceutical Pharmaceutical Analysis Services Product Portfolio Table 110. West Pharmaceutical Recent Development Table 111. Microbac Company Information Table 112. Microbac Business Overview Table 113. Microbac Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 114. Microbac Pharmaceutical Analysis Services Product Portfolio Table 115. Microbac Recent Development Table 116. Element (Analytical Lab Group) Company Information Table 117. Element (Analytical Lab Group) Business Overview Table 118. Element (Analytical Lab Group) Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 119. Element (Analytical Lab Group) Pharmaceutical Analysis Services Product Portfolio Table 120. Element (Analytical Lab Group) Recent Development Table 121. Piramal Pharma Solutions Company Information Table 122. Piramal Pharma Solutions Business Overview Table 123. Piramal Pharma Solutions Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 124. Piramal Pharma Solutions Pharmaceutical Analysis Services Product Portfolio Table 125. Piramal Pharma Solutions Recent Development Table 126. CTI Company Information Table 127. CTI Business Overview Table 128. CTI Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 129. CTI Pharmaceutical Analysis Services Product Portfolio Table 130. CTI Recent Development Table 131. Weipu Company Information Table 132. Weipu Business Overview Table 133. Weipu Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 134. Weipu Pharmaceutical Analysis Services Product Portfolio Table 135. Weipu Recent Development Table 136. PONY Medicine Company Information Table 137. PONY Medicine Business Overview Table 138. PONY Medicine Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 139. PONY Medicine Pharmaceutical Analysis Services Product Portfolio Table 140. PONY Medicine Recent Development Table 141. North America Pharmaceutical Analysis Services Market Size by Type (2021-2026) & (US$ Million) Table 142. North America Pharmaceutical Analysis Services Market Size by Type (2027-2032) & (US$ Million) Table 143. North America Pharmaceutical Analysis Services Market Size by Application (2021-2026) & (US$ Million) Table 144. North America Pharmaceutical Analysis Services Market Size by Application (2027-2032) & (US$ Million) Table 145. North America Pharmaceutical Analysis Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. North America Pharmaceutical Analysis Services Market Size by Country (2021-2026) Table 147. North America Pharmaceutical Analysis Services Market Size by Country (2027-2032) Table 148. Europe Pharmaceutical Analysis Services Market Size by Type (2021-2026) & (US$ Million) Table 149. Europe Pharmaceutical Analysis Services Market Size by Type (2027-2032) & (US$ Million) Table 150. Europe Pharmaceutical Analysis Services Market Size by Application (2021-2026) & (US$ Million) Table 151. Europe Pharmaceutical Analysis Services Market Size by Application (2027-2032) & (US$ Million) Table 152. Europe Pharmaceutical Analysis Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 153. Europe Pharmaceutical Analysis Services Market Size by Country (2021-2026) Table 154. Europe Pharmaceutical Analysis Services Market Size by Country (2027-2032) Table 155. China Pharmaceutical Analysis Services Market Size by Type (2021-2026) & (US$ Million) Table 156. China Pharmaceutical Analysis Services Market Size by Type (2027-2032) & (US$ Million) Table 157. China Pharmaceutical Analysis Services Market Size by Application (2021-2026) & (US$ Million) Table 158. China Pharmaceutical Analysis Services Market Size by Application (2027-2032) & (US$ Million) Table 159. Asia Pharmaceutical Analysis Services Market Size by Type (2021-2026) & (US$ Million) Table 160. Asia Pharmaceutical Analysis Services Market Size by Type (2027-2032) & (US$ Million) Table 161. Asia Pharmaceutical Analysis Services Market Size by Application (2021-2026) & (US$ Million) Table 162. Asia Pharmaceutical Analysis Services Market Size by Application (2027-2032) & (US$ Million) Table 163. Asia Pharmaceutical Analysis Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 164. Asia Pharmaceutical Analysis Services Market Size by Country (2021-2026) Table 165. Asia Pharmaceutical Analysis Services Market Size by Country (2027-2032) Table 166. South America, Middle East & Africa Pharmaceutical Analysis Services Market Size by Type (2021-2026) & (US$ Million) Table 167. South America, Middle East & Africa Pharmaceutical Analysis Services Market Size by Type (2027-2032) & (US$ Million) Table 168. South America, Middle East & Africa Pharmaceutical Analysis Services Market Size by Application (2021-2026) & (US$ Million) Table 169. South America, Middle East & Africa Pharmaceutical Analysis Services Market Size by Application (2027-2032) & (US$ Million) Table 170. South America, Middle East & Africa Pharmaceutical Analysis Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. South America, Middle East & Africa Pharmaceutical Analysis Services Market Size by Country (2021-2026) Table 172. South America, Middle East & Africa Pharmaceutical Analysis Services Market Size by Country (2027-2032) Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources Table 176. Primary Sources List of Figures Figure 1. Pharmaceutical Analysis Services Product Image Figure 2. Global Pharmaceutical Analysis Services Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Pharmaceutical Analysis Services Market Share by Type: 2025 VS 2032 Figure 4. Raw Material Analysis Image Figure 5. Microbiological Analysis Image Figure 6. Drug Packaging Material Analysis Image Figure 7. Biological Analysis and Testing Image Figure 8. Other Image Figure 9. Global Pharmaceutical Analysis Services Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Pharmaceutical Analysis Services Market Share by Application: 2025 VS 2032 Figure 11. CRO Image Figure 12. CMO and CDMO Image Figure 13. Finished Drugs and Environment Image Figure 14. Global Pharmaceutical Analysis Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Pharmaceutical Analysis Services Market Size (2021-2032) & (US$ Million) Figure 16. Global Pharmaceutical Analysis Services Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Pharmaceutical Analysis Services Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Pharmaceutical Analysis Services Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Pharmaceutical Analysis Services Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Pharmaceutical Analysis Services Revenue Market Share by Type (2021-2032) Figure 23. Global Pharmaceutical Analysis Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Pharmaceutical Analysis Services Revenue Market Share by Application (2021-2032) Figure 25. North America Pharmaceutical Analysis Services Market Size (2021-2032) & (US$ Million) Figure 26. North America Pharmaceutical Analysis Services Market Share by Type (2021-2032) Figure 27. North America Pharmaceutical Analysis Services Market Share by Application (2021-2032) Figure 28. North America Pharmaceutical Analysis Services Market Share by Country (2021-2032) Figure 29. United States Pharmaceutical Analysis Services Market Size (2021-2032) & (US$ Million) Figure 30. Canada Pharmaceutical Analysis Services Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Pharmaceutical Analysis Services Market Size (2021-2032) & (US$ Million) Figure 32. Europe Pharmaceutical Analysis Services Market Size (2021-2032) & (US$ Million) Figure 33. Europe Pharmaceutical Analysis Services Market Share by Type (2021-2032) Figure 34. Europe Pharmaceutical Analysis Services Market Share by Application (2021-2032) Figure 35. Europe Pharmaceutical Analysis Services Market Share by Country (2021-2032) Figure 36. Germany Pharmaceutical Analysis Services Market Size (2021-2032) & (US$ Million) Figure 37. France Pharmaceutical Analysis Services Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Pharmaceutical Analysis Services Market Size (2021-2032) & (US$ Million) Figure 39. Italy Pharmaceutical Analysis Services Market Size (2021-2032) & (US$ Million) Figure 40. Russia Pharmaceutical Analysis Services Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Pharmaceutical Analysis Services Market Size (2021-2032) & (US$ Million) Figure 42. China Pharmaceutical Analysis Services Market Size (2021-2032) & (US$ Million) Figure 43. China Pharmaceutical Analysis Services Market Share by Type (2021-2032) Figure 44. China Pharmaceutical Analysis Services Market Share by Application (2021-2032) Figure 45. Asia Pharmaceutical Analysis Services Market Size (2021-2032) & (US$ Million) Figure 46. Asia Pharmaceutical Analysis Services Market Share by Type (2021-2032) Figure 47. Asia Pharmaceutical Analysis Services Market Share by Application (2021-2032) Figure 48. Asia Pharmaceutical Analysis Services Market Share by Country (2021-2032) Figure 49. Japan Pharmaceutical Analysis Services Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Pharmaceutical Analysis Services Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Pharmaceutical Analysis Services Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Pharmaceutical Analysis Services Market Size (2021-2032) & (US$ Million) Figure 53. India Pharmaceutical Analysis Services Market Size (2021-2032) & (US$ Million) Figure 54. Australia Pharmaceutical Analysis Services Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Pharmaceutical Analysis Services Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Pharmaceutical Analysis Services Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Pharmaceutical Analysis Services Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Pharmaceutical Analysis Services Market Share by Country (2021-2032) Figure 59. Brazil Pharmaceutical Analysis Services Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Pharmaceutical Analysis Services Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Pharmaceutical Analysis Services Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Pharmaceutical Analysis Services Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Pharmaceutical Analysis Services Market Size (2021-2032) & (US$ Million) Figure 64. UAE Pharmaceutical Analysis Services Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Pharmaceutical Analysis Services Market Size (2021-2032) & (US$ Million) Figure 66. Chile Pharmaceutical Analysis Services Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Raw Material Analysis
  • Microbiological Analysis
  • Drug Packaging Material Analysis
  • Biological Analysis and Testing
  • Other
Applications
  • CRO
  • CMO and CDMO
  • Finished Drugs and Environment
Companies covered
  • Eurofins
  • WuXi AppTec
  • Pace Analytical Services
  • Catalent
  • LabCorp (Covance)
  • PPD
  • Element (Exova)
  • ALS Pharmaceutical
  • Intertek Group
  • SGS
  • Boston Analytical
  • DYNALABS
  • ADPEN Laboratories
  • ARL Bio Pharma
  • West Pharmaceutical
  • Microbac
  • Element (Analytical Lab Group)
  • Piramal Pharma Solutions
  • CTI
  • Weipu
  • PONY Medicine

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Pharmaceutical Analysis Services Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Raw Material Analysis
  5. 1.2.3 Microbiological Analysis
  6. 1.2.4 Drug Packaging Material Analysis
  7. 1.2.5 Biological Analysis and Testing
  8. 1.2.6 Other
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Pharmaceutical Analysis Services Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 CRO
  12. 1.3.3 CMO and CDMO
  13. 1.3.4 Finished Drugs and Environment
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Pharmaceutical Analysis Services Growth Trends by Region
  16. 1.5.1 Global Pharmaceutical Analysis Services Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Pharmaceutical Analysis Services Market Size by Region (2021-2026)
  18. 1.5.3 Pharmaceutical Analysis Services Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Pharmaceutical Analysis Services Market Dynamics
  1. 2.1 Pharmaceutical Analysis Services Industry Trends
  2. 2.2 Pharmaceutical Analysis Services Industry Drivers
  3. 2.3 Pharmaceutical Analysis Services Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Analysis Services Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Pharmaceutical Analysis Services Revenue by Company (2021-2026)
  2. 3.2 Global Pharmaceutical Analysis Services Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Pharmaceutical Analysis Services Key Company Head office and Area Served
  4. 3.4 Global Pharmaceutical Analysis Services Company, Product Type & Application
  5. 3.5 Global Pharmaceutical Analysis Services Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Pharmaceutical Analysis Services Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Pharmaceutical Analysis Services Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Pharmaceutical Analysis Services Tier 1, Tier 2, and Tier 3
4 Pharmaceutical Analysis Services Market by Type
  1. 4.1 Global Pharmaceutical Analysis Services Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Pharmaceutical Analysis Services Market Size by Type (2021-2032)
  3. 4.3 Global Pharmaceutical Analysis Services Market Size Share by Type (2021-2032)
5 Pharmaceutical Analysis Services Market by Application
  1. 5.1 Global Pharmaceutical Analysis Services Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Pharmaceutical Analysis Services Market Size by Application (2021-2032)
  3. 5.3 Global Pharmaceutical Analysis Services Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Eurofins
  2. 6.1.1 Eurofins Company Information
  3. 6.1.2 Eurofins Business Overview
  4. 6.1.3 Eurofins Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Eurofins Pharmaceutical Analysis Services Product Portfolio
  6. 6.1.5 Eurofins Recent Developments
  7. 6.2 WuXi AppTec
  8. 6.2.1 WuXi AppTec Company Information
  9. 6.2.2 WuXi AppTec Business Overview
  10. 6.2.3 WuXi AppTec Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 WuXi AppTec Pharmaceutical Analysis Services Product Portfolio
  12. 6.2.5 WuXi AppTec Recent Developments
  13. 6.3 Pace Analytical Services
  14. 6.3.1 Pace Analytical Services Company Information
  15. 6.3.2 Pace Analytical Services Business Overview
  16. 6.3.3 Pace Analytical Services Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Pace Analytical Services Pharmaceutical Analysis Services Product Portfolio
  18. 6.3.5 Pace Analytical Services Recent Developments
  19. 6.4 Catalent
  20. 6.4.1 Catalent Company Information
  21. 6.4.2 Catalent Business Overview
  22. 6.4.3 Catalent Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Catalent Pharmaceutical Analysis Services Product Portfolio
  24. 6.4.5 Catalent Recent Developments
  25. 6.5 LabCorp (Covance)
  26. 6.5.1 LabCorp (Covance) Company Information
  27. 6.5.2 LabCorp (Covance) Business Overview
  28. 6.5.3 LabCorp (Covance) Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 LabCorp (Covance) Pharmaceutical Analysis Services Product Portfolio
  30. 6.5.5 LabCorp (Covance) Recent Developments
  31. 6.6 PPD
  32. 6.6.1 PPD Company Information
  33. 6.6.2 PPD Business Overview
  34. 6.6.3 PPD Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 PPD Pharmaceutical Analysis Services Product Portfolio
  36. 6.6.5 PPD Recent Developments
  37. 6.7 Element (Exova)
  38. 6.7.1 Element (Exova) Company Information
  39. 6.7.2 Element (Exova) Business Overview
  40. 6.7.3 Element (Exova) Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Element (Exova) Pharmaceutical Analysis Services Product Portfolio
  42. 6.7.5 Element (Exova) Recent Developments
  43. 6.8 ALS Pharmaceutical
  44. 6.8.1 ALS Pharmaceutical Company Information
  45. 6.8.2 ALS Pharmaceutical Business Overview
  46. 6.8.3 ALS Pharmaceutical Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 ALS Pharmaceutical Pharmaceutical Analysis Services Product Portfolio
  48. 6.8.5 ALS Pharmaceutical Recent Developments
  49. 6.9 Intertek Group
  50. 6.9.1 Intertek Group Company Information
  51. 6.9.2 Intertek Group Business Overview
  52. 6.9.3 Intertek Group Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Intertek Group Pharmaceutical Analysis Services Product Portfolio
  54. 6.9.5 Intertek Group Recent Developments
  55. 6.10 SGS
  56. 6.10.1 SGS Company Information
  57. 6.10.2 SGS Business Overview
  58. 6.10.3 SGS Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 SGS Pharmaceutical Analysis Services Product Portfolio
  60. 6.10.5 SGS Recent Developments
  61. 6.11 Boston Analytical
  62. 6.11.1 Boston Analytical Company Information
  63. 6.11.2 Boston Analytical Business Overview
  64. 6.11.3 Boston Analytical Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Boston Analytical Pharmaceutical Analysis Services Product Portfolio
  66. 6.11.5 Boston Analytical Recent Developments
  67. 6.12 DYNALABS
  68. 6.12.1 DYNALABS Company Information
  69. 6.12.2 DYNALABS Business Overview
  70. 6.12.3 DYNALABS Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 DYNALABS Pharmaceutical Analysis Services Product Portfolio
  72. 6.12.5 DYNALABS Recent Developments
  73. 6.13 ADPEN Laboratories
  74. 6.13.1 ADPEN Laboratories Company Information
  75. 6.13.2 ADPEN Laboratories Business Overview
  76. 6.13.3 ADPEN Laboratories Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 ADPEN Laboratories Pharmaceutical Analysis Services Product Portfolio
  78. 6.13.5 ADPEN Laboratories Recent Developments
  79. 6.14 ARL Bio Pharma
  80. 6.14.1 ARL Bio Pharma Company Information
  81. 6.14.2 ARL Bio Pharma Business Overview
  82. 6.14.3 ARL Bio Pharma Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 ARL Bio Pharma Pharmaceutical Analysis Services Product Portfolio
  84. 6.14.5 ARL Bio Pharma Recent Developments
  85. 6.15 West Pharmaceutical
  86. 6.15.1 West Pharmaceutical Company Information
  87. 6.15.2 West Pharmaceutical Business Overview
  88. 6.15.3 West Pharmaceutical Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 West Pharmaceutical Pharmaceutical Analysis Services Product Portfolio
  90. 6.15.5 West Pharmaceutical Recent Developments
  91. 6.16 Microbac
  92. 6.16.1 Microbac Company Information
  93. 6.16.2 Microbac Business Overview
  94. 6.16.3 Microbac Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Microbac Pharmaceutical Analysis Services Product Portfolio
  96. 6.16.5 Microbac Recent Developments
  97. 6.17 Element (Analytical Lab Group)
  98. 6.17.1 Element (Analytical Lab Group) Company Information
  99. 6.17.2 Element (Analytical Lab Group) Business Overview
  100. 6.17.3 Element (Analytical Lab Group) Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Element (Analytical Lab Group) Pharmaceutical Analysis Services Product Portfolio
  102. 6.17.5 Element (Analytical Lab Group) Recent Developments
  103. 6.18 Piramal Pharma Solutions
  104. 6.18.1 Piramal Pharma Solutions Company Information
  105. 6.18.2 Piramal Pharma Solutions Business Overview
  106. 6.18.3 Piramal Pharma Solutions Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Piramal Pharma Solutions Pharmaceutical Analysis Services Product Portfolio
  108. 6.18.5 Piramal Pharma Solutions Recent Developments
  109. 6.19 CTI
  110. 6.19.1 CTI Company Information
  111. 6.19.2 CTI Business Overview
  112. 6.19.3 CTI Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 CTI Pharmaceutical Analysis Services Product Portfolio
  114. 6.19.5 CTI Recent Developments
  115. 6.20 Weipu
  116. 6.20.1 Weipu Company Information
  117. 6.20.2 Weipu Business Overview
  118. 6.20.3 Weipu Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Weipu Pharmaceutical Analysis Services Product Portfolio
  120. 6.20.5 Weipu Recent Developments
  121. 6.21 PONY Medicine
  122. 6.21.1 PONY Medicine Company Information
  123. 6.21.2 PONY Medicine Business Overview
  124. 6.21.3 PONY Medicine Pharmaceutical Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  125. 6.21.4 PONY Medicine Pharmaceutical Analysis Services Product Portfolio
  126. 6.21.5 PONY Medicine Recent Developments
7 North America
  1. 7.1 North America Pharmaceutical Analysis Services Market Size (2021-2032)
  2. 7.2 North America Pharmaceutical Analysis Services Market Size by Type
  3. 7.2.1 North America Pharmaceutical Analysis Services Market Size by Type (2021-2026)
  4. 7.2.2 North America Pharmaceutical Analysis Services Market Size by Type (2027-2032)
  5. 7.2.3 North America Pharmaceutical Analysis Services Market Share by Type (2021-2032)
  6. 7.3 North America Pharmaceutical Analysis Services Market Size by Application
  7. 7.3.1 North America Pharmaceutical Analysis Services Market Size by Application (2021-2026)
  8. 7.3.2 North America Pharmaceutical Analysis Services Market Size by Application (2027-2032)
  9. 7.3.3 North America Pharmaceutical Analysis Services Market Share by Application (2021-2032)
  10. 7.4 North America Pharmaceutical Analysis Services Market Size by Country
  11. 7.4.1 North America Pharmaceutical Analysis Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Pharmaceutical Analysis Services Market Size by Country (2021-2026)
  13. 7.4.3 North America Pharmaceutical Analysis Services Market Size by Country (2027-2032)
  14. 7.4.4 North America Pharmaceutical Analysis Services Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Pharmaceutical Analysis Services Market Size (2021-2032)
  2. 8.2 Europe Pharmaceutical Analysis Services Market Size by Type
  3. 8.2.1 Europe Pharmaceutical Analysis Services Market Size by Type (2021-2026)
  4. 8.2.2 Europe Pharmaceutical Analysis Services Market Size by Type (2027-2032)
  5. 8.2.3 Europe Pharmaceutical Analysis Services Market Share by Type (2021-2032)
  6. 8.3 Europe Pharmaceutical Analysis Services Market Size by Application
  7. 8.3.1 Europe Pharmaceutical Analysis Services Market Size by Application (2021-2026)
  8. 8.3.2 Europe Pharmaceutical Analysis Services Market Size by Application (2027-2032)
  9. 8.3.3 Europe Pharmaceutical Analysis Services Market Share by Application (2021-2032)
  10. 8.4 Europe Pharmaceutical Analysis Services Market Size by Country
  11. 8.4.1 Europe Pharmaceutical Analysis Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Pharmaceutical Analysis Services Market Size by Country (2021-2026)
  13. 8.4.3 Europe Pharmaceutical Analysis Services Market Size by Country (2027-2032)
  14. 8.4.4 Europe Pharmaceutical Analysis Services Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Pharmaceutical Analysis Services Market Size (2021-2032)
  2. 9.2 China Pharmaceutical Analysis Services Market Size by Type
  3. 9.2.1 China Pharmaceutical Analysis Services Market Size by Type (2021-2026)
  4. 9.2.2 China Pharmaceutical Analysis Services Market Size by Type (2027-2032)
  5. 9.2.3 China Pharmaceutical Analysis Services Market Share by Type (2021-2032)
  6. 9.3 China Pharmaceutical Analysis Services Market Size by Application
  7. 9.3.1 China Pharmaceutical Analysis Services Market Size by Application (2021-2026)
  8. 9.3.2 China Pharmaceutical Analysis Services Market Size by Application (2027-2032)
  9. 9.3.3 China Pharmaceutical Analysis Services Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Pharmaceutical Analysis Services Market Size (2021-2032)
  2. 10.2 Asia Pharmaceutical Analysis Services Market Size by Type
  3. 10.2.1 Asia Pharmaceutical Analysis Services Market Size by Type (2021-2026)
  4. 10.2.2 Asia Pharmaceutical Analysis Services Market Size by Type (2027-2032)
  5. 10.2.3 Asia Pharmaceutical Analysis Services Market Share by Type (2021-2032)
  6. 10.3 Asia Pharmaceutical Analysis Services Market Size by Application
  7. 10.3.1 Asia Pharmaceutical Analysis Services Market Size by Application (2021-2026)
  8. 10.3.2 Asia Pharmaceutical Analysis Services Market Size by Application (2027-2032)
  9. 10.3.3 Asia Pharmaceutical Analysis Services Market Share by Application (2021-2032)
  10. 10.4 Asia Pharmaceutical Analysis Services Market Size by Country
  11. 10.4.1 Asia Pharmaceutical Analysis Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Pharmaceutical Analysis Services Market Size by Country (2021-2026)
  13. 10.4.3 Asia Pharmaceutical Analysis Services Market Size by Country (2027-2032)
  14. 10.4.4 Asia Pharmaceutical Analysis Services Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Pharmaceutical Analysis Services Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Pharmaceutical Analysis Services Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Pharmaceutical Analysis Services Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Pharmaceutical Analysis Services Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Pharmaceutical Analysis Services Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Pharmaceutical Analysis Services Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Pharmaceutical Analysis Services Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Pharmaceutical Analysis Services Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Pharmaceutical Analysis Services Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Pharmaceutical Analysis Services Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Pharmaceutical Analysis Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Pharmaceutical Analysis Services Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Pharmaceutical Analysis Services Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Pharmaceutical Analysis Services Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst